FFA
NVO

Frazier Financial Advisors’s Novo Nordisk NVO Stock Holding History

Frazier Financial Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$51.6K Sell
1,404
-3,074
-69% -$146K 0.03% 180
2025
Q4 		$228K Buy
4,478
+1,550
+53% +$79.3K 0.13% 59
2025
Q3 		$162K Buy
2,928
+200
+7% +$11.7K 0.1% 74
2025
Q2 		$188K Buy
2,728
+371
+16% +$25.2K 0.13% 63
2025
Q1 		$164K Buy
2,357
+90
+4% +$7.43K 0.13% 62
2024
Q4 		$194K Sell
2,267
-103
-4% -$11.1K 0.15% 55
2024
Q3 		$282K Buy
2,370
+514
+28% +$68.5K 0.22% 41
2024
Q2 		$265K Buy
1,856
+118
+7% +$15.6K 0.21% 47
2024
Q1 		$223K Buy
1,738
+215
+14% +$25.6K 0.18% 51
2023
Q4 		$158K Buy
+1,523
New +$151K 0.14% 57

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Frazier Financial Advisors's NVO Position: Q1 2026 in Review

Frazier Financial Advisors reduced its Novo Nordisk (NVO) stake by 69% in Q1 2026, selling an estimated $146K and leaving 1,404 shares worth $51.6K. The position accounts for 0.03% of the portfolio, ranked #180.

Frazier Financial Advisors first reported a position in NVO in Q4 2023 and has held it in 10 quarters since. The position peaked at $282K in Q3 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Frazier Financial Advisors held 1,404 shares of Novo Nordisk worth $51.6K as of Q1 2026.
  • Frazier Financial Advisors sold 3,074 Novo Nordisk shares in Q1 2026, an estimated $146K.
  • Novo Nordisk made up 0.03% of Frazier Financial Advisors's portfolio in Q1 2026, its #180 holding.
  • Frazier Financial Advisors first reported a position in Novo Nordisk in Q4 2023 and has held it in 10 quarters since.
  • Frazier Financial Advisors's Novo Nordisk position peaked at $282K in Q3 2024.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Frazier Financial Advisors's 13F filing for Q1 2026, filed 5 May 2026.